+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030 - Product Thumbnail Image

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

  • Report
  • March 2020
  • 306 Pages
  • Global
From
Biological Drug API Manufacturing Services Market Report 2023-2033 - Product Thumbnail Image

Biological Drug API Manufacturing Services Market Report 2023-2033

  • Report
  • December 2023
  • 261 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 220 Pages
  • Global
From
Fibromyalgia Therapeutics Market by Drug Class, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Fibromyalgia Therapeutics Market by Drug Class, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 184 Pages
  • Global
From
Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028

  • Report
  • September 2024
  • 167 Pages
  • Global
From
Neuromuscular Disease Therapeutics Market 2023-2027 - Product Thumbnail Image

Neuromuscular Disease Therapeutics Market 2023-2027

  • Report
  • October 2023
  • 163 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 115 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2024-2032 - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2024-2032

  • Report
  • April 2024
  • 136 Pages
  • Global
From
Duchenne Muscular Dystrophy Global Market Report 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Duchenne Muscular Dystrophy (DMD) Therapeutics Global Market Report 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Limb Girdle Muscular Dystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

Limb Girdle Muscular Dystrophy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Duchenne Muscular Dystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Duchenne Muscular Dystrophy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Duchenne Muscular Dystrophy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 170 Pages
  • Global
Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 218 Pages
  • Global
From
Dystrophin (DMD) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dystrophin (DMD) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 133 Pages
  • Global
From
Non-Viral / Intracellular Drug Delivery Systems Market by Type of Molecule, Type of Biologics Delivered, Type of Vehicle Used, Type of Therapeutic Area, Type of Payments and Key Geographies: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Non-Viral / Intracellular Drug Delivery Systems Market by Type of Molecule, Type of Biologics Delivered, Type of Vehicle Used, Type of Therapeutic Area, Type of Payments and Key Geographies: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • January 2023
  • 270 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 366 Pages
  • Global
From
Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions - Product Thumbnail Image

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

  • Report
  • December 2023
  • 799 Pages
  • Global
From
Co-Promotion and Co-Marketing in Pharmaceuticals and Biotechnology 2014-2024 - Product Thumbnail Image

Co-Promotion and Co-Marketing in Pharmaceuticals and Biotechnology 2014-2024

  • Report
  • September 2024
  • 250 Pages
  • Global
From
Loading Indicator